1 / 2

Patients with VTE or VTE-Related Death(%)

AMPLIFY: first event of recurrent VTE with apixaban or conventional therapy. Patients with VTE or VTE-Related Death(%). Agnelli et al., NEJM 2013. AMPLIFY: first major bleeding episode with apixaban or conventional therapy. Patients with Major Bleeding (%).

oma
Download Presentation

Patients with VTE or VTE-Related Death(%)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. AMPLIFY: firstevent of recurrent VTE withapixabanorconventionaltherapy Patients with VTE or VTE-Related Death(%) Agnelliet al., NEJM 2013

  2. AMPLIFY: first major bleeding episode withapixabanorconventionaltherapy Patientswith Major Bleeding (%) Agnelliet al., NEJM 2013

More Related